Other
No intervention administered
No intervention administered is an intervention with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Other(1)
Detailed Status
Recruiting2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Trials by Status
unknown125%
recruiting250%
not_yet_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
not_yet_recruiting
Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC
NCT06904547
recruiting
Modelling of Correlation Between Emergency Department Admissions and Location-specific Air Quality and Weather in the Florence Urban Area
NCT06491290
unknown
Benchmarking Integrated Care for People Living With Huntington's Disease in England
NCT05828992
recruiting
Clinical and Genetic Analysis of ROP
NCT04420156
Clinical Trials (4)
Showing 4 of 4 trials
NCT06904547
Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC
NCT06491290
Modelling of Correlation Between Emergency Department Admissions and Location-specific Air Quality and Weather in the Florence Urban Area
NCT05828992
Benchmarking Integrated Care for People Living With Huntington's Disease in England
NCT04420156
Clinical and Genetic Analysis of ROP
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4